{"id":420,"date":"2017-07-26T15:47:51","date_gmt":"2017-07-26T15:47:51","guid":{"rendered":"https:\/\/www.ampac1.com\/blog\/effect-of-increased-water-intake-on-plasma-copeptin-in-healthy-adults\/"},"modified":"2026-04-13T00:00:00","modified_gmt":"2026-04-13T00:00:00","slug":"effect-of-increased-water-intake-on-plasma-copeptin-in-healthy-adults","status":"publish","type":"post","link":"https:\/\/www.ampac1.com\/blog\/effect-of-increased-water-intake-on-plasma-copeptin-in-healthy-adults\/","title":{"rendered":"Effect of increased water intake on plasma copeptin in healthy adults"},"content":{"rendered":"

Quick Answer:<\/strong> Copeptin is a stable peptide co-released with vasopressin (antidiuretic hormone) in response to osmotic stress and dehydration. Research demonstrates that increasing daily water intake in mildly hypohydrated healthy adults significantly reduces plasma copeptin concentrations, a biomarker of adequate. Advanced water treatment technologies including reverse osmosis provide effective solutions for water quality challenges in this area. AMPAC USA’s commercial and industrial systems are engineered to address these specific water treatment needs with certified, documented performance.<\/p>\n

Published online: June 3 2017 European Journal of Nutrition (IF 3.239). \u00a0Guillaume Lemetais \u00b7 Olle Melander \u00b7 Mariacristina Vecchio \u00b7 Jeanne H. Bottin \u00b7
\nSofa Enh\u00f6rning \u00b7 Erica T. Perrier<\/p>\n

\n

Abstract<\/h3>\n
\n

PURPOSE:<\/h4>\n

Inter-individual variation in median plasma copeptin is associated with incident type 2 diabetes mellitus, progression of chronic kidney disease, and cardiovascular events. In this study, we examined whether 24-h urine osmolality was associated with plasma copeptin and whether increasing daily water intake could impact circulating plasma copeptin.<\/p>\n

METHODS:<\/h4>\n

This trial was a prospective study conducted at a single investigating center. Eighty-two healthy adults (age 23.6\u00a0\u00b1\u00a02.9\u00a0years, BMI 22.2\u00a0\u00b1\u00a01.5\u00a0kg\/m2<\/sup>, 50% female) were stratified based upon habitual daily fluid intake volumes: arm A (50-80% of EFSA dietary reference values), arm B (81-120%), and arm C (121-200%). Following a baseline visit, arms A and B increased their water intake to match arm C for a period of 6 consecutive weeks.<\/p>\n

RESULTS:<\/h4>\n

At baseline, plasma copeptin was positively and significantly associated with 24-h urine osmolality (p\u00a0=\u00a00.002) and 24-h urine specific gravity (p\u00a0=\u00a00.003) but not with plasma osmolality (p\u00a0=\u00a00.18), 24-h urine creatinine (p\u00a0=\u00a00.09), and total fluid intake (p\u00a0=\u00a00.52). Over the 6-week follow-up, copeptin decreased significantly from 5.18 (3.3;7.4) to 3.90 (2.7;5.7) pmol\/L (p\u00a0=\u00a00.012), while urine osmolality and urine specific gravity decreased from 591\u00a0\u00b1\u00a0206 to 364\u00a0\u00b1\u00a0117\u00a0mOsm\/kg (p\u00a0<\u00a00.001) and from 1.016\u00a0\u00b1\u00a00.005 to 1.010\u00a0\u00b1\u00a00.004 (p\u00a0<\u00a00.001), respectively.<\/p>\n

CONCLUSIONS:<\/h4>\n

At baseline, circulating levels of copeptin were positively associated with 24-h urine concentration in healthy young subjects with various fluid intakes. Moreover, this study shows, for the first time, that increased water intake over 6\u00a0weeks results in an attenuation of circulating copeptin.<\/p>\n

CLINICAL TRIAL REGISTRATION NUMBER:<\/h4>\n

NCT02044679.<\/p>\n<\/div>\n<\/div>\n

\n

KEYWORDS:<\/h4>\n

Copeptin; Fluid intake; Hydration; Urine osmolality; Water intake<\/p>\n<\/div>\n

Effect of increased water intake on plasma copeptin in healthy adults<\/p>\n

 <\/p>\n

The post Effect of increased water intake on plasma copeptin in healthy adults appeared first on Facts About Water.<\/p>\n

Source: Water Feed<\/p>\n

\n<\/div>\n

\n

What flow rates are available for emergency water treatment?<\/h3>\n
\n

AMPAC USA's emergency systems range from 1,500 GPD portable units to 50,000+ GPD trailer-mounted systems. Military-specification units are available for forward operating base deployment, producing potable water meeting EPA and WHO drinking water standards from virtually any source.<\/p>\n<\/div>\n<\/div>\n

\n

Are emergency RO systems suitable for disaster relief operations?<\/h3>\n
\n

Yes. AMPAC USA's emergency systems are used by FEMA, the U.S. military, and international NGOs for disaster relief. They treat flood water, contaminated groundwater, and brackish sources, removing bacteria, viruses, and chemical contaminants to produce safe drinking water on-site.<\/p>\n<\/div>\n<\/div>\n

\n

What power sources can emergency water purification systems use?<\/h3>\n
\n

AMPAC USA's emergency systems can run on generator power (120\/240V or 480V 3-phase), solar panels with battery backup, or vehicle power take-off (PTO). Low-power models consume as little as 0.5 kW, making them viable for off-grid deployment.<\/p>\n<\/div>\n<\/div>\n

\n

How durable are military-grade water purification systems?<\/h3>\n
\n

AMPAC USA's military systems are built to MIL-SPEC standards with stainless steel frames, powder-coated components, and UV-resistant materials. They are designed to operate in temperatures from -20\u00b0F to 120\u00b0F and are vibration-tested for transport in military vehicles.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Conclusion<\/h2>\n

This post highlighted how emergency and military-grade water purification systems provide safe drinking water rapidly in the most challenging field conditions. For organizations requiring deployable water treatment capability, AMPAC USA engineers portable and trailer-mounted systems built to perform wherever they are needed. Contact our team at info@ampac1.com or (909) 548-4900 to discuss your emergency water treatment requirements.<\/p>\n<\/div>\n

Water Intake Hydration Copeptin Plasma Healthy Adults: Technical Analysis and Solutions<\/h2>\n

Copeptin is a stable peptide co-released with vasopressin (antidiuretic hormone) in response to osmotic stress and dehydration. Research demonstrates that increasing daily water intake in mildly hypohydrated healthy adults significantly reduces plasma copeptin concentrations, a biomarker of adequate hydration status. Since many adults are chronically mildly dehydrated, improving access to palatable, filtered water is a practical public health intervention with measurable physiological benefits.<\/p>\n

Understanding the science behind water quality challenges in this area enables selection of appropriately engineered treatment solutions. Water treatment technology selection should be based on comprehensive source water analysis, contaminant characterization, and performance-verified system design.<\/p>\n

Reverse osmosis systems<\/strong> from AMPAC USA provide multi-contaminant treatment capability through TFC polyamide membranes achieving 90\u201399% rejection of dissolved contaminants, combined with sediment pre-filtration, activated carbon treatment, and UV disinfection options. Our commercial and industrial systems are NSF\/ANSI certified, providing documented performance evidence for regulatory compliance and quality assurance programs.<\/p>\n

For specific water quality challenges in this application area, AMPAC USA’s engineering team provides source water analysis review, system sizing recommendations, and complete treatment train design to ensure water quality objectives are reliably achieved. Contact AMPAC USA to discuss your specific water treatment requirements.<\/p>\n

\n

Frequently Asked Questions<\/h2>\n
\n

What is reverse osmosis water purification?<\/h3>\n
\n

Reverse osmosis forces water under pressure through a semi-permeable membrane (0.0001 \u00b5m pores) that rejects 90\u201399% of dissolved contaminants while allowing pure water molecules to pass through. It is widely considered the most effective point-of-use water treatment technology.<\/p>\n<\/div>\n<\/div>\n

\n

What contaminants does reverse osmosis remove?<\/h3>\n
\n

RO removes dissolved salts (TDS), heavy metals (lead, arsenic, chromium), nitrates, fluoride, PFAS, pharmaceuticals, bacteria, viruses, and most organic contaminants through a combination of size exclusion, charge repulsion, and hydrophobic rejection mechanisms.<\/p>\n<\/div>\n<\/div>\n

\n

How does water quality affect public health?<\/h3>\n
\n

Access to safe, clean drinking water is fundamental to human health. Contaminated water causes an estimated 500,000 diarrheal deaths annually worldwide and contributes to chronic health conditions through long-term exposure to heavy metals, nitrates, PFAS, and other regulated and unregulated contaminants.<\/p>\n<\/div>\n<\/div>\n

\n

When should I consider a water purification system?<\/h3>\n
\n

Consider water purification if your water has detectable lead, nitrates, arsenic, PFAS, or other contaminants; if you have a private well; if your water tastes or smells off; if you have immunocompromised family members; or if you want to reduce your dependence on bottled water.<\/p>\n<\/div>\n<\/div>\n

\n

What is the difference between water filtering and water purification?<\/h3>\n
\n

Filtration physically removes particles and some dissolved compounds from water. Purification (including RO) achieves more comprehensive removal of dissolved contaminants through pressure-driven membrane separation. RO is considered purification because it removes dissolved ionic species that filtration alone cannot address.<\/p>\n<\/div>\n<\/div>\n

\n

How often does a water purification system need maintenance?<\/h3>\n
\n

Reverse osmosis systems require pre-filter replacements every 6\u201312 months, membrane replacement every 2\u20135 years, and annual system sanitization. Well-maintained systems provide consistent, high-quality water for 10\u201315+ years with these routine service intervals.<\/p>\n<\/div>\n<\/div>\n

\n

Does AMPAC USA offer water treatment systems for this application?<\/h3>\n
\n

Yes. AMPAC USA provides residential, commercial, and industrial water treatment systems including reverse osmosis, UV disinfection, and multi-stage treatment solutions designed for specific water quality challenges. Our systems are NSF\/ANSI certified for performance verification and customer confidence.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Inter-individual variation in median plasma copeptin is associated with incident type 2 diabetes mellitus, progression of chronic kidney disease, and cardiovascular events<\/p>\n","protected":false},"author":1,"featured_media":88012,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[24],"tags":[22],"class_list":["post-420","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-water-filter","tag-ro"],"_links":{"self":[{"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/posts\/420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/comments?post=420"}],"version-history":[{"count":5,"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/posts\/420\/revisions"}],"predecessor-version":[{"id":88088,"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/posts\/420\/revisions\/88088"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/media\/88012"}],"wp:attachment":[{"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/media?parent=420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/categories?post=420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ampac1.com\/blog\/wp-json\/wp\/v2\/tags?post=420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}